The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 21, 2020

Filed:

May. 02, 2018
Applicant:

B. Braun Avitum Ag, Melsungen, DE;

Inventors:

Angela Baier-Goschütz, Bad Gottleuba-Berggiesshübel, DE;

Alexander Friebe, Recklinghausen, DE;

Roland Napierala, Werther, DE;

Juliane Gäbler, Pulsnitz, DE;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
B01J 20/24 (2006.01); B01J 20/28 (2006.01); A61M 1/34 (2006.01); B01J 20/30 (2006.01); B01J 20/32 (2006.01); B01J 20/26 (2006.01); A61M 1/36 (2006.01);
U.S. Cl.
CPC ...
B01J 20/24 (2013.01); A61M 1/3486 (2014.02); A61M 1/3679 (2013.01); B01J 20/265 (2013.01); B01J 20/267 (2013.01); B01J 20/28038 (2013.01); B01J 20/3085 (2013.01); B01J 20/321 (2013.01); B01J 20/3208 (2013.01); B01J 20/3212 (2013.01); B01J 20/3221 (2013.01); B01J 20/3274 (2013.01); B01J 20/3282 (2013.01); B01J 20/3289 (2013.01); A61M 1/3413 (2013.01); B01J 2220/4825 (2013.01);
Abstract

A hemocompatible adsorber for separating protein-bound uremic toxins contained in the blood of a patient and having a molecular mass of <500 g/mol regarding their carrier proteins, to adsorb the uremic toxins during hemodialysis. The hemocompatible adsorber including a polymer based on a cyclic oligosaccharide or a derivative thereof which is disposed on a solid carrier component. A device for hemodiafiltration including an extracorporeal circuit for receiving blood to be purified and a hemodialyzer connected to the blood circulation of a patient, wherein a hemocompatible adsorber is provided for separating protein-bound uremic toxins contained in the blood of a patient and having a molecular mass of <500 g/mol regarding their carrier proteins. The hemocompatible adsorber, which is disposed on a solid carrier component in at least one layer on the blood side within the hemodialyzer, includes a polymer based on a cyclic oligosaccharide or a derivative thereof.


Find Patent Forward Citations

Loading…